Dalrada Financial Corporation Files Form 10-Q, Announces Third Quarter Revenue of $10.3 Million

May 16, 2024

Company’s pharmaceutical subsidiary continues to drive impressive growth accounting for nearly 80% of Q3 2024 revenue

SAN DIEGO, May 16, 2024 (GLOBE NEWSWIRE) — Dalrada Financial Corporation (OTCQB: DFCO, “Dalrada,” “the Company”), announced today it had filed a Form 10-Q for the quarter ended March 31, 2024, posting $10.3 million in revenue and highlighting consistent revenue generation, particularly from its specialty pharmacy subsidiary.

Read more at globenewswire.com

Related news for (DFCO)

NASDAQ and NYSE quotes and data are delayed 15 minutes unless indicated otherwise. Market data and exchange information are provided for informational purposes only and is not intended for trading purposes. Neither 24/7 Market News Editors, 247 Market News, or data and content providers shall be liable for any errors or omissions, delays, misquotes or other market information relayed in any press materials. You should Use Realtime data to conduct due diligence before investing or trading, and trading in any stock is risky you could lose all your money.